KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

LifeMD (LFMD) Long-Term Deferred Tax (2025)

LifeMD filings provide 1 years of Long-Term Deferred Tax readings, the most recent being $19.0 million for Q4 2025.

On a quarterly basis, Long-Term Deferred Tax changed N/A to $19.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.0 million, a N/A change, with the full-year FY2025 number at $19.0 million, changed N/A from a year prior.
Long-Term Deferred Tax hit $19.0 million in Q4 2025 for LifeMD.
In the past five years, Long-Term Deferred Tax ranged from a high of $19.0 million in Q4 2025 to a low of $19.0 million in Q4 2025.